Articles
Outsourcing supply chain and buffer preparation activities
As the biopharmaceutical market evolves and continues a steep upward trajectory of growth, biopharmaceutical drug innovators increasingly rely on contract development and manufacturing organizations (CDMOs) to help them achieve their mission.
The Innovation Imperative: Pioneering New Modalities for Therapeutic Leadership
In the rapidly evolving landscape of pharmaceuticals and biotechnology, the emergence of multimodal drug discovery heralds a transformative era for drug discovery, where innovation and strategic Foresight are paramount.
From early innovations to commercial triumphs: One viral vector partner for every stage of gene therapy development
Viral vector-based gene therapies hold promise for treating previously untreatable diseases like genetic disorders, rare cancers, and infectious diseases.
